The present invention relates to extended release tablets for oral administration comprising clarithromycin and a pharmaceutically acceptable carrier, wherin the pharmaceutically acceptable carrier comprises a mixture of lactose and microcrysalline cellulose in a ration ranging from 3:1 to 1:3, and processes for their preparation.
